Esquema para la implementación de atención farmacéutica para pacientes diabéticos tipo 2 del Hospital Teodoro Maldonado Carbo del Instituto Ecuatoriano de Seguridad Social (IESS) en el área de consulta externa. Guayaquil, 2016
Fecha
2017
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil. Facultad de Ciencias Químicas
Resumen
La Atención Farmacéutica (Pharmaceutical Care) , surge a principios de los años 90, con el objetivo de dar solución y respuesta al gran número de morbi-mortalidad por medicamentos, producto del incremento de la complejidad de las terapias farmacológicas y al aumento de la esperanza de vida .Se propuso la implementación del ESQUEMA de Programa de Atención Farmacéutica (DADER) ,en pacientes diabéticos tipo 2 , con el objetivo de optimizar las terapias farmacológicas y modificar los hábitos de vida, para lograr un mejor control de la enfermedad. Se realizó un estudio prospectivo y controlado, en pacientes diabéticos tipo 2 del hospital Teodoro Maldonado Carbo del Instituto Ecuatoriano de Seguridad Social (IESS) ,área de consulta externa. En los últimos años se han incrementado los índices de enfermedades crónico-degenerativas como Diabetes mellitus (DM), Hipertensión Arterial y la Hipertrigliceridemia, que se colocan entre las primeras causas de fallecimiento. En esta investigación narrativa, bibliográfica y no experimental se realizó en pacientes diabéticos tipo 2, con una duración de 8 meses. Los pacientes seleccionados, que debían cumplir los criterios de inclusión fueron divididos al azar en dos grupos, intervenido y control. Se detectaron 108 problemas relacionados con medicamentos (PRM), de los cuales 68 afectaron al grupo intervenido y 40 al grupo control. Se solucionaron un total de 54 PRM, 46 PRM de ellos identificados en los intervenidos y 8 PRM en los controles. El PRM de mayor frecuencia fue el de “Incumplimiento del tratamiento farmacológico” con un 52,8%, seguido por el de “Reacción adversa” con un 21,3%. Este trabajo recopilo la información basada en los datos de pacientes diagnosticado con diabetes mellitus tipo 2 del Hospital Teodoro Maldonado Carbo durante el año 2016, donde el método DADER propuesto, permitirá una mejor atención a los pacientes, que se reflejará en una mejor comunicación paciente y farmacéutico, lo que permitirá el control más eficiente de los tratamientos suministrados, aumentado así la calidad de vida de los pacientes.
Pharmaceutical Care emerged in the early 1990s with the aim of solving and responding to the large number of drug morbidity and mortality resulting from the increased complexity of pharmacological therapies and increased hope Of life. It was proposed the implementation of the SCHEME of Pharmaceutical Care Program (DADER), in type 2 diabetic patients, with the objective of optimizing pharmacological therapies and modifying life habits, to achieve a better control of the disease. A prospective and controlled study was conducted in type 2 diabetic patients at the Teodoro Maldonado Carbo Hospital of the Ecuadorian Social Security Institute (IESS), an area of external consultation. In recent years, the rates of chronic-degenerative diseases such as Diabetes mellitus (DM), Arterial Hypertension and Hypertriglyceridemia, which are among the first causes of death. In this narrative, bibliographical and non-experimental investigation was carried out in type 2 diabetic patients, with a duration of 8 months. The selected patients, who had to meet the inclusion criteria were randomly divided into two groups, operated and controlled. There were 108 drug-related problems (PRM), of which 68 affected the intervention group and 40 affected the control group. A total of 54 PRMs were resolved, 46 PRMs identified in the interventions and 8 PRMs in the controls. The most frequent PRM was "Non-compliance with pharmacological treatment" with 52.8%, followed by "Adverse reaction" with 21.3%. This paper compiles information based on the data of patients diagnosed with type 2 diabetes mellitus of the Teodoro Maldonado Carbo Hospital during the year 2016, where the proposed DADER method will allow better patient care, which will be reflected in a better patient and Pharmaceutical, which will allow more efficient control of the treatments provided, thus increasing the quality of life of patients.
Pharmaceutical Care emerged in the early 1990s with the aim of solving and responding to the large number of drug morbidity and mortality resulting from the increased complexity of pharmacological therapies and increased hope Of life. It was proposed the implementation of the SCHEME of Pharmaceutical Care Program (DADER), in type 2 diabetic patients, with the objective of optimizing pharmacological therapies and modifying life habits, to achieve a better control of the disease. A prospective and controlled study was conducted in type 2 diabetic patients at the Teodoro Maldonado Carbo Hospital of the Ecuadorian Social Security Institute (IESS), an area of external consultation. In recent years, the rates of chronic-degenerative diseases such as Diabetes mellitus (DM), Arterial Hypertension and Hypertriglyceridemia, which are among the first causes of death. In this narrative, bibliographical and non-experimental investigation was carried out in type 2 diabetic patients, with a duration of 8 months. The selected patients, who had to meet the inclusion criteria were randomly divided into two groups, operated and controlled. There were 108 drug-related problems (PRM), of which 68 affected the intervention group and 40 affected the control group. A total of 54 PRMs were resolved, 46 PRMs identified in the interventions and 8 PRMs in the controls. The most frequent PRM was "Non-compliance with pharmacological treatment" with 52.8%, followed by "Adverse reaction" with 21.3%. This paper compiles information based on the data of patients diagnosed with type 2 diabetes mellitus of the Teodoro Maldonado Carbo Hospital during the year 2016, where the proposed DADER method will allow better patient care, which will be reflected in a better patient and Pharmaceutical, which will allow more efficient control of the treatments provided, thus increasing the quality of life of patients.
Descripción
Pdf
Palabras clave
DIABETES MELLITUS TIPO 2, ATENCIÓN FARMACÉUTICA, SEGUIMIENTO FARMACOTERAPEUTICO, PROBLEMA RELACIONADO CON LOS MEDICAMENTOS